InnoTherapy Receives Commendation from MFDS Commissioner on Medical Device Day

[Asia Economy Reporter Hyunseok Yoo] Innotherapy, an innovative hemostatic agent development company, announced on the 23rd that it received the Minister of Food and Drug Safety Award at the '13th Medical Device Day' ceremony.

Innotherapy independently developed a unique new substance protected by global patents and succeeded in commercializing it as a hemostatic agent. Through various certifications, the company is on the verge of entering the global market.

Innotherapy is gaining attention in the domestic medical device market, which is mainly focused on imported and copycat products, by obtaining approval as a Class 4 medical device through comparative clinical trials with hemostatic products launched by global pharmaceutical companies. The company explained that this award signifies the government's support as it begins full-scale efforts to globalize K-medical devices, building on its success in the domestic market.

Moonsoo Lee, CEO of Innotherapy, said, "I accept this award as recognition by the government of our efforts over the past 10 years and as encouragement to further advance and actively promote the globalization of K-medical devices." He added, "We will not be satisfied with our achievements so far and will devote ourselves to developing innovative products, including quarantine materials to prevent multiple waves of COVID-19 infections."

Meanwhile, Innotherapy has started discussions with pharmaceutical companies regarding sales by bundling existing and improved products.

This content was produced with the assistance of AI translation services.